Literature DB >> 12954115

Coupling of RNAi-mediated target downregulation with gene replacement.

Dong-Ho Kim1, John J Rossi.   

Abstract

Short interfering RNA (siRNA)-mediated knockdown of deleterious endogenous transcripts has potential applications for the treatment of hereditary diseases. In situations where the mutant and wildtype transcripts cannot be discriminated from one another by siRNAs, it may be necessary to simultaneously carry out gene replacement with a modified form of the target RNA that is resistant to siRNA activity. To test this possibility, we have taken advantage of a potent siRNA that knocks down EGFP mRNA. In this system, wild-type EGFP expression is suppressed by the siRNA, whereas an EGFP construct with codon modifications in the target region that is otherwise fully functional is not downregulated. When expression of the wild-type message is inhibited, EGFP expression can be simultaneously restored by transfecting these cells with the codon-modified version of EGFP. These studies provide a detailed methodology and system for testing this strategy with RNA interference (RNAi).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12954115     DOI: 10.1089/108729003768247619

Source DB:  PubMed          Journal:  Antisense Nucleic Acid Drug Dev        ISSN: 1087-2906


  14 in total

1.  Artificial mirtron-mediated gene knockdown: functional DMPK silencing in mammalian cells.

Authors:  Yiqi Seow; Christopher R Sibley; Matthew J A Wood
Journal:  RNA       Date:  2012-05-30       Impact factor: 4.942

2.  The GeneOptimizer Algorithm: using a sliding window approach to cope with the vast sequence space in multiparameter DNA sequence optimization.

Authors:  David Raab; Marcus Graf; Frank Notka; Thomas Schödl; Ralf Wagner
Journal:  Syst Synth Biol       Date:  2010-09-01

3.  Improved retinal function in a mouse model of dominant retinitis pigmentosa following AAV-delivered gene therapy.

Authors:  Naomi Chadderton; Sophia Millington-Ward; Arpad Palfi; Mary O'Reilly; Gearóid Tuohy; Marian M Humphries; Tiansen Li; Peter Humphries; Paul F Kenna; G Jane Farrar
Journal:  Mol Ther       Date:  2009-01-27       Impact factor: 11.454

4.  RNAi-mediated TCR knockdown prevents autoimmunity in mice caused by mixed TCR dimers following TCR gene transfer.

Authors:  Mario Bunse; Gavin M Bendle; Carsten Linnemann; Laura Bies; Stephan Schulz; Ton N Schumacher; Wolfgang Uckert
Journal:  Mol Ther       Date:  2014-07-22       Impact factor: 11.454

5.  Simultaneous knockdown of the expression of two genes using multiple shRNAs and subsequent knock-in of their expression.

Authors:  Xue-Ming Xu; Min-Hyuk Yoo; Bradley A Carlson; Vadim N Gladyshev; Dolph L Hatfield
Journal:  Nat Protoc       Date:  2009-08-27       Impact factor: 13.491

6.  A new strategy for assessing selenoprotein function: siRNA knockdown/knock-in targeting the 3'-UTR.

Authors:  Min-Hyuk Yoo; Xue-Ming Xu; Anton A Turanov; Bradley A Carlson; Vadim N Gladyshev; Dolph L Hatfield
Journal:  RNA       Date:  2007-04-27       Impact factor: 4.942

Review 7.  Lentiviral delivery of short hairpin RNAs.

Authors:  N Manjunath; Haoquan Wu; Sandesh Subramanya; Premlata Shankar
Journal:  Adv Drug Deliv Rev       Date:  2009-03-31       Impact factor: 15.470

8.  Impact of target mRNA structure on siRNA silencing efficiency: A large-scale study.

Authors:  Joseph A Gredell; Angela K Berger; S Patrick Walton
Journal:  Biotechnol Bioeng       Date:  2008-07-01       Impact factor: 4.530

9.  RNA interference-mediated suppression and replacement of human rhodopsin in vivo.

Authors:  Mary O'Reilly; Arpad Palfi; Naomi Chadderton; Sophia Millington-Ward; Marius Ader; Thérèse Cronin; Thérèse Tuohy; Alberto Auricchio; Markus Hildinger; Amanda Tivnan; Niamh McNally; Marian M Humphries; Anna-Sophia Kiang; Pete Humphries; Paul F Kenna; G Jane Farrar
Journal:  Am J Hum Genet       Date:  2007-05-23       Impact factor: 11.025

10.  Computational codon optimization of synthetic gene for protein expression.

Authors:  Bevan Kai-Sheng Chung; Dong-Yup Lee
Journal:  BMC Syst Biol       Date:  2012-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.